Therapeutic Targets

MAKScientific's technology provides an excellent opportunity to create novel and highly effective medications without the undesirable psychotropic side effects associated with cannabis.  The Company has designed and synthesized compounds that are in advanced preclinical development for the treatment of:

• obesity and metabolic disorders
  

• neuropathic and inflammatory pain
  

• addiction

• neurodegenerative diseases

MAKScientific has highly developed tools and technologies that it employs in the course of its research in the areas of medicinal chemistry, molecular biology and molecular modeling.  The Company holds an extensive library of over 12,000 carefully designed druggable compounds covering the key therapeutic areas it is pursuing.  It also has proprietary cell culture lines and sophisticated biochemical and pharmacological assays as well as animal models to further its drug discovery efforts.